Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points

Table 2 Antipsychotics prescribed on discharge

Class	Route	First AP		Second AP		Third AP
SGA		C1	C2	C1	C2	C1	C2
Amisulpride	PO	2	5	2	5
Aripiprazole	LAI		1
Aripiprazole	PO	4	10	2	1
Asenapine	PO	2			1
Clozapine	PO	17	13		2
Olanzapine	LAI	4			1
Olanzapine	PO	45	45	12	16
Paliperidone	LAI	18	34	3	7
Paliperidone	PO		1	1
Quetiapine	PO	39	31	6	7	2
Rispiridone	LAI	13	6	5	4
Rispiridone	PO	34	38	11	14
Ziprasidone	PO	3	1
Subtotal	IM	35	41	8	12
	PO	146	144	34	46	2
FGA		C1	C2	C1	C2	C1	C2
Chlorpromazine	PO	2	2	1	3	2
Flupenthixol	LAI	2	2	3	3
Fluphenazine	LAI				2
Haloperidol	LAI	2		1
Haloperidol	PO	2	1	1	1
Zuclopenthixol	LAI	11	10	5	6
Zuclopenthixol	PO			2	1
Subtotal	IM	15	12	9	11
	PO	4	3	4	5	2
AP Total	IM	50	53	17	23
	PO	150	147	38	51	4
TOTAL		200	200	55	74	4

SGA Second generation antipsychotic, FGA First generation antipsychotic, PO oral; LAI Long-acting injection, AP Antipsychotic, C1 Cohort 1, C2 Cohort 2

ISSN: 1471-244X